This Support Is Useful When
-
Your team has received an FDA Additional Information request, deficiency communication, or other formal request for clarification.
-
The response is being managed through scattered email threads, individual spreadsheets, and disconnected document versions.
-
Multiple functions—engineering, quality, clinical, regulatory, labeling, manufacturing, suppliers, or outside laboratories—need to provide input.
-
The underlying technical evidence may exist, but it is difficult to locate, explain, reconcile, or connect to the relevant FDA question.
-
You need a structured way to identify what is known, what is missing, who owns each input, and what must be reviewed before submission.
-
Your internal experts need to spend their time validating technical content rather than tracking documents, formatting responses, or reconciling comments.
-
You have a response deadline approaching and need additional documentation capacity.
What you receive
What FDA RFI Hold Rescue Can Include
The final scope depends on the FDA communication, the number and type of questions, available source materials, number of contributors, and timeline. Typical deliverables may include:
-
A plain-language breakdown of FDA questions or requests.
-
A question-by-question response tracker.
-
An assigned-owner and contributor list.
-
An evidence inventory identifying available reports, records, data, prior submission sections, labeling, and supporting materials.
-
A document-gap list identifying missing, unclear, inconsistent, or incomplete inputs.
-
Affected-document map showing which submission sections, tables, labeling, manuals, risk records, or attachments may require review or revision.
-
Draft response narratives based on approved client and SME input.
-
Editing and organization of response attachments and revised documentation.
-
Version-control and review-status tracking.
-
Internal review packages and consolidated-comment coordination.
-
A final response-package structure for client regulatory review and submission preparation.
How the work proceeds
A Practical Response Process
1. Triage the communication
We review the FDA communication, current response deadline, available submission materials, known stakeholders, and immediate documentation risks.
2. Break the request into manageable actions
Each question is translated into a trackable work item with an owner, source-material needs, technical-input needs, document impact, open gaps, and review status.
3. Build the evidence trail
I help organize the information needed to support each response, identify where evidence is missing or unclear, and connect supporting materials to the relevant FDA question.
4. Draft and refine response materials
I draft, edit, structure, and revise the written response materials using confirmed inputs from your qualified subject-matter experts.
5. Prepare for internal review
The work is consolidated into a review-ready package so your engineering, quality, regulatory, clinical, and leadership reviewers can assess the response more efficiently.
Every FDA Request Becomes a Trackable Response Item
Our Standard, Due Diligient Response
FDA communications may include numbered deficiencies, grouped requests, or questions embedded within an email or letter. In a high-pressure response, teams can unintentionally focus on the easiest or most familiar issues first—while a required question, supporting attachment, linked document revision, or internal review step remains unresolved.
My approach begins by converting each FDA request into a structured response matrix. Each item is tracked from initial interpretation through evidence collection, subject-matter-expert input, document revision, internal review, and final response preparation.
The goal is not simply to produce a persuasive narrative. It is to establish a clear record showing that every FDA request was identified, assigned, addressed, reviewed, and accounted for.
Scope boundary
Documentation Support, Not Technical Validation
FDA RFI Hold Rescue focuses on documentation planning, question tracking, evidence mapping, document-gap identification, drafting, editing, organization, traceability support, version management, and review coordination.
I do not independently perform or certify engineering calculations, scientific analyses, laboratory testing, statistical analysis, clinical evaluation, software validation, usability testing, cybersecurity testing, biocompatibility assessment, sterilization validation, risk acceptance, or final technical or regulatory decisions.
Your qualified internal personnel, regulatory lead, legal counsel, laboratories, and specialist providers remain responsible for the technical evidence, validation activities, scientific conclusions, and final submission decisions.
Why this matters
The First Response Should Not Be “Start Writing”
FDA requests for additional information may involve missing, unclear, insufficient, or inadequately supported information that FDA needs to complete its review. A productive response starts by understanding exactly what is being requested, what was already provided, what supporting evidence exists, and what must be clarified or developed.
In many cases, the immediate problem is not a lack of technical knowledge. It is the absence of a shared response structure: one place to track each question, the evidence that supports it, the person responsible for input, the affected documents, the remaining gap, and the status of review.
That is the documentation problem FDA RFI Hold Rescue is designed to help solve.
Pricing section
Clear Starting Points for FDA RFI Response Support
Every FDA information request is different. Scope depends on the number and complexity of questions, submission type, available source materials, number of internal and external contributors, document revisions required, response timeline, and the extent of coordination needed.
The options below provide planning ranges for focused documentation support. Final scope, deliverables, assumptions, review cycles, and pricing are confirmed in writing before work begins.
| Engagement |
Starting Investment |
| FDA RFI Response Assessment |
From $1,500 |
| FDA RFI Documentation Sprint |
From $3,500 |
| FDA RFI Response Coordination Project |
From $7,500 |
| Extended Response Support |
Custom scope or monthly retainer |
Pricing assumptions
What “Starting Investment” Means
Starting investments apply to well-defined documentation work with available source materials, agreed deliverables, a manageable number of stakeholders, and up to two consolidated client review cycles.
Final pricing may change if the project requires accelerated turnaround, extensive document recovery, new source-material development, substantial rewriting of the original submission, multiple stakeholder groups, repeated or uncoordinated review cycles, major changes in direction, new FDA communications, or additional deliverables.
The service does not include testing, engineering analysis, statistical work, clinical work, regulatory legal advice, or other specialist activities outside the documentation scope.
FAQ section
Is an FDA RFI or Additional Information request a final rejection?
Not necessarily. FDA may request additional information when it needs more information to complete review. The specific type of communication, submission pathway, question content, and response deadline should be reviewed carefully by the client’s qualified regulatory lead and subject-matter experts.
Can you answer FDA’s technical questions for us?
I support the organization, drafting, editing, evidence mapping, document tracking, and review coordination involved in the response. Qualified client subject-matter experts, laboratories, clinical specialists, and regulatory personnel remain responsible for technical evidence, testing, analyses, scientific conclusions, and final regulatory decisions.
Can you work with our regulatory consultant or legal counsel?
Yes. FDA RFI Hold Rescue can support internal regulatory teams, outside consultants, legal counsel, laboratories, engineering teams, and other specialist providers by helping create a clear documentation workflow and review-ready written materials.
Can you help if we do not know what documents we have?
Yes. An FDA RFI Response Assessment can begin with document inventory and evidence mapping. The initial goal is to identify what exists, where it is located, which materials support each question, and where additional input or evidence is needed.
Can you guarantee FDA will accept our response or remove the hold?
No. FDA decisions depend on the adequacy of the technical, clinical, regulatory, quality, and other supporting information provided. This service helps your team organize and present documentation more clearly; it does not guarantee an FDA review outcome.